Figure 2.
Assessment and Treatment of Non-alcoholic Fatty Liver Disease in Type 2 Diabetes. ACE: Angiotensin converting enzyme; ARB: Angiotensin-II receptor antagonists or blockers; BMI: body mass index; EGFR: estimated glomerular filtration rate; GLP-1: Glucagon-like Peptide-1; MS: Metabolic surgery; SGLT2: Sodium-glucose cotransporter 2; TG: Triglycerides; * Triumvirate Lifestyle Intervention.